Engineering Life Forward

Medicine
at the edge
of possible

Pioneering therapeutic technologies that restore function, alleviate pain, and extend life for millions of patients worldwide.

98.7%
Therapy Success Rate
Lives Improved
82M+
Across 150 countries
R&D Pipeline
340+
Active clinical studies
82M+
Patients Served Annually
150+
Countries Reached
$3B
Annual R&D Investment
95K+
Global Employees
Our Focus

Therapy Areas

From cardiac care to neuroscience, our portfolio spans the most critical intersections of disease and technology.

🫀

Cardiac Rhythm

Advanced pacemakers, defibrillators, and cardiac monitoring systems designed to keep hearts beating with precision.

Learn More →
🧠

Neuromodulation

Neurostimulation therapies for Parkinson's, chronic pain, and treatment-resistant depression, redefining quality of life.

Learn More →
💉

Diabetes Care

Continuous glucose monitoring and automated insulin delivery systems that give patients freedom and control.

Learn More →
🦴

Spine & Ortho

Surgical navigation, biologics, and implant solutions that restore mobility across the spine and major joints.

Learn More →
🔬

Surgical Robotics

AI-assisted robotic platforms that deliver unmatched precision for minimally invasive and complex procedures.

Learn More →
🫁

ENT & Respiratory

Innovative therapies for obstructive sleep apnea, sinusitis, and respiratory conditions affecting millions daily.

Learn More →
Why MedDevice

Built on three core pillars

Our approach to innovation is rooted in science, driven by compassion, and delivered with accountability.

01

Deep Science

Our research teams operate at the frontier of biology, engineering, and data science—translating discovery into therapies that matter.

02

Patient-First

Every decision we make starts with the patient. We partner with clinical experts and advocacy communities to design solutions that genuinely improve lives.

03

Global Reach

Operating in over 150 countries, we ensure that breakthrough technologies are accessible wherever patients need them most.

Newsroom

Latest from MedDevice

All News →
Innovation
March 10, 2026
New closed-loop insulin delivery study shows 40% reduction in hypoglycemic events
Partnership
March 5, 2026
MedDevice and Johns Hopkins launch joint neuromodulation research center

Ready to explore partnership?

Whether you're a healthcare professional, a patient, or an institution, we're here to help navigate the future of therapeutic medicine.

Find a Physician Partner With Us